Company Filing History:
11 out of 2,930 
3 out of 634 
1 out of 50 
Years Active: 2017-2023
Title: Innovations in Gene Therapy: The Work of Shannon Elizabeth Boye
Introduction
Shannon Elizabeth Boye, an accomplished inventor based in Gainesville, FL, has made significant contributions to the field of gene therapy, particularly concerning retinal disorders. With a remarkable portfolio of 11 patents, her research focuses on innovative methods for treating eye diseases, showcasing both her dedication and expertise in the biomedical sciences.
Latest Patents
Among her latest patents, Boye has developed groundbreaking methods and compositions for treating cone-rod retinal dystrophy. This disorder, specifically identified as cone-rod dystrophy type 6 (CORD6), can be addressed through her proposed techniques, which involve administering a therapeutically effective amount of nucleic acids to patients. This approach aims to treat conditions associated with dominant mutations in the guanylate cyclase 2D (GUCY2D) gene, potentially offering hope for those affected by this genetic condition. Furthermore, she has contributed to advancements in gene delivery systems using recombinant AAV particles. These particles hold promise for effectively targeting retinal cells, using modified AAV capsid proteins to enhance the transduction process.
Career Highlights
Boye's career has been marked by her association with esteemed institutions, including the University of Florida Research Foundation and the UAB Research Foundation. Her innovative research and patent filings illustrate her commitment to addressing complex medical challenges and enhancing patient outcomes through scientific excellence.
Collaborations
Collaboration has been a cornerstone of Boye's career. She has worked closely with notable professionals in her field, including Sanford Leon Boye and William W. Hauswirth. These collaborations highlight the importance of teamwork in advancing scientific knowledge and developing effective therapeutic solutions.
Conclusion
Shannon Elizabeth Boye's pioneering work in the realm of gene therapy and her substantial patent portfolio underscore her role as a leading inventor. Her innovations have the potential to transform the landscape of treatment for retinal disorders, providing hope and solutions for patients facing these challenging conditions. Through her research and collaborations, Boye exemplifies the spirit of innovation that drives progress in the field of biomedical sciences.